Hypertensive diabetic rats in pharmacological studies

Pharmacological Research

Volumn 33, Issue 2, 1996, Pages 95-105

  Van Zwieten, P A ^a   Kam, K L ^a   Pijl, A J ^a   Hendriks, M G C ^a   Beenen, O H M ^a   Pfaffendorf, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cardiovascular system; Diabetes mellitus; Hypertension; Obese Zucker rats; Streptozotocin hypertensive rats

Indexed keywords

CROMAKALIM; GLIBENCLAMIDE; METHOXAMINE; NITROPRUSSIDE SODIUM; NORADRENALIN; SEROTONIN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL MODEL; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; HEMODYNAMICS; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES;

EID: 0030087589     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0015     Document Type: Article

References (44)

1. 1. Yamori Y. Development of the spontaneously hypertensive rat (SHR) and of various spontaneous rat models, and their implications. In: de Jong W, ed. Handbook of hypertension, Vol. 4. Amsterdam: Elsevier, 1984: 224-39.
2. 2. Yamori Y. The stroke-prone spontaneously hypertensive rat: contribution to risk factor analysis and prevention of hypertensive diseases. In: de Jong W, eds. Handbook of hypertension, Vol. 4. Amsterdam: Elsevier, 1984: 240-55.
3. 3. Leenen FHH, Myers MG. Pressor mechanisms in renovascular rats. In: de Jong W, ed. Handbook of hypertension, Vol. 4. Amsterdam: Elsevier, 1984: 24-53.
4. 4. Karasik A, Hattori M. Use of animal models in the study of diabetes. In: Kahn CR, Weir GC, eds. Joslin's diabetes mellitus, 13th edn. Philadelphia, PA: Lea & Febiger, 1994: 217-350.
5. 5. Fischer LJ. Drugs and chemicals that produce diabetes. Trends Pharmacol Sci 1985; 6: 72-5.
6. 6. Chappel CI, Chappel WR. The discovery and development of the BB rat colony: an animal model of spontaneous diabetes mellitus. Metabolism 1983; 32: 8-10.
7. 7. Factor SM, Bhan RAJ, Minase T, Wolinsky H, Sonnenblick EH. Hypertensive-diabetic cardiomyopathy in the rat, an experimental model of human disease. Am J Pathol 1981; 102: 219-28.
8. 8. Rodgers RL. Depressor effect of diabetes in the spontaneously hypertensive rat: associated changes in heart performance. Can J Physiol Pharmacol 1986; 64: 1177-84.
9. 9. Clark JB, Palmer J, Shaw WN. The diabetic Zucker fatty rat (41611). Proc Soc Exp Biol Med 1983; 173: 68-75.
10. 10. Kurtz TW, Morris RC, Pershadsingh HA. The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 1989; 13: 897-901.
11. 11. Bray GA. The Zucker-fatty rat: a review. Fed Proc 1977; 148-53.
12. 12. Kasiske BL, O'Donnell MP, Keane WF. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 1992; 19: I-1 10-5.
13. 13. Hendriks MGC, Kam KL, Pijl AJ, Pfaffendorf M, van Zwieten PA. The effects of hypertension and diabetes mellitus on the vascular reactivity of resistance arteries. Blood Press 1993; 2: 69-76.
14. 14. Kam KL, Hendriks MGC, Pijl AJ, Pfaffendorf M, van Zwieten PA. Spontaneously hypertensive rats with diabetes: effects of some vasoconstrictors on isolated small arteries. J Hypertens 1993; 11 (Suppl. 5): S120-1.
15. 15. Kam KL, Hendriks MGC, Pijl AJ, van Marle J, van Veen HA, Pfaffendorf M, van Zwieten PA. Contractile responses to various stimuli in isolated resistance vessels from simultaneously hypertensive and streptozotocin-diabetic rats. J Cardiovasc Pharmacol 1996; 27: 167-75.
16. 16. Pijl AJ, van der Wal AC, Mathy MJ, Kam KL, Hendriks MGC, Pfaffendorf M, van Zwieten PA. Streptozotocininduced diabetes mellitus in spontaneously hypertensive rats: a pathophysiological model for the combined effects of hypertension and diabetes. J Pharm Methods 1994; 32: 225-33.
17. 17. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43: 854-64.
18. 18. Warshaw DM, Mulvany MJ, Halpern W. Mechanical and morphological properties of arterial resistance vessels in young and old spontaneously hypertensive rats. Circ Res 1979; 45: 250-9.
19. 19. Mulvany MJ, Aalkjaer C, Christensen J. Changes in noradrenaline sensitivity and morphology of arterial resistance vessels during development of high blood pressure in spontaneously hypertensive rats. Hypertension 1980; 2: 664-71.
20. 20. Regan TJ, Ettinger PO, Kahn MI, et al. Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res 1974; 35: 222-37.
21. 21. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985; 27: 255-70.
22. 22. Factor SM, Minase T, Cho S, Fein F, Capasso JM, Sonnenblick EH. Coronary microvascular abnormalities in the hypertensive-diabetic rat, a primary cause of cardiomyopathy? Am J Pathol 1984; 116: 9-20.
23. 23. Somani P, Singh HP, Saini RK, Rabinovitch A. Streptozotocin-induced diabetes in the spontaneously hypertensive rat. Metabolism 979; 28: 1075-7.
24. 24. Agraawal DK, McNeill JH. Effect of diabetes on vascular smooth muscle function in normotensive and spontaneously hypertensive rat mesenteric artery. Can J Physiol Pharmacol 1981; 65: 2274-80.
25. 25. Tomlinson KC, Gardiner SM, Hebden RA, Bennet T. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 1992; 44: 103-50.
26. 26. Zemel MB, Sowers JR, Shehin S, Walsh MF, Levy J. Impaired calcium metabolism associated with hypertension in Zucker obese rats. Metabolism 1990; 39: 704-8.
27. 27. McCaleb ML, Sredy J. Metabolic abnormalities of the hyperglycemic obese Zucker rat. Metabolism 1992; 41: 522-5.
28. 28. Paulson DJ, Tahiliani AG. Cardiovascular abnormalities associated with human and rodent obesity. Life Sci 1992; 51: 1557-69.
29. 29. Johnson IR, Curwen JO, Wilbraham JM, Hatton R. Differences in blood pressure, heart rate and vascular reactivity in the obese and lean Zucker rat. Br J Pharmacol 1994; 112 (Suppl.): 200P.
30. 30. Folkow B, Karlstrom G. Vascular reactivity in hypertension: importance of structural influences. J Cardiovasc Pharmacol 1987; 10 (Suppl. 4): 525-30.
31. 31. Folkow B. Structural factor in primary and secondary hypertension. Hypertension 1990; 16: 89-100.
32. 32. Jie K, van Brummelen P, van Zwieten PA. α-adrenoceptors in blood vessels of the human forearm. Prog Pharmacol 1986; 6: 37-45.
33. 33. van Zwieten PA. Adrenergic and muscarinic receptors. Classification, pathophysiological relevance and drug target. J Hypertens 1991; 9 (Suppl. 6): S18-27.
34. 34. Kam KL. Diabetes mellitus and/or hypertension in various pathological models (a pharmacological study). PhD Thesis. University of Amsterdam, 1994: 75-98.
35. 35. Kam KL, Pfaffendorf M, van Zwieten PA. Drug-induced endothelium dependent and -independent relaxations in isolated resistance vessels taken from simultaneously hypertensive and streptozotocin-diabetic rats. Blood Press 1994; 3: 418-27.
36. 36. Beenen OHM, Pfaffendorf M, van Zwieten PA. Contractile responses to various inotropic agents in isolated hearts obtained from hypertensive diabetic rats. Blood Press 1995; 4: 372-8.
37. 1-adrenoceptor mediated vasoconstriction in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 1983; 324: 239-45.
38. 38. Pijl AJ, Hendriks MGC, Kam KL, Pfaffendorf M, van Zwieten PA. Anti-ischemic effects of nifedipine in isolated working heart preparations of healthy, diabetic and hypertensive rats. J Cardiovasc Pharmacol 1994; 23: 379-86.
39. 39. Pijl AJ, Hendriks MGC, Kam KL, Pfaffendorf M, van Zwieten PA. Effects of R 56865 on postischemic ventricular function in isolated rat working heart preparations obtained from healthy, diabetic and hypertensive animals. Naunyn-Schmiedeberg's Arch Pharmacol 1994; 349: 619-26.
40. 40. Beenen OHM, Mathy MJ, Pfaffendorf M, van Zwieten PA. Influence of nifedipine on pressor responses induced by different α-adrenoceptor agonists and angiotensin II in pithed diabetic hypertensive rats. Submitted.
41. 41. Kam KL, Pfaffendorf M, van Zwieten PA. Pharmacodynamic behaviour of isolated resistance vessels obtained from hypertensive diabetic rats. Fundam Clin Pharmacol 1996; in press.
42. 42. Cox RH, Kikta DC. Age-related changes in thoracic aorta of obese Zucker rats. Am J Physiol 1992; 262: H1584-H1556.
43. 43. Auget M, Delaflotte S, Braquet P. Increased influence of endothelium in obese Zucker rat aorta. J Pharm Pharmacol 1989; 41: 861-4.
44. 44. Zemel MB, Peuler JD, Sowers JR, Simpson L. Hypertension in insulin-resistance Zucker obese rats is independent of sympathetic neural support. Am J Physiol 1992; 262: E368-73.